loading
전일 마감가:
$7.00
열려 있는:
$5.86
하루 거래량:
134.37K
Relative Volume:
3.08
시가총액:
$611.37M
수익:
$5.12M
순이익/손실:
$-67.00M
주가수익비율:
-4.4966
EPS:
-1.47
순현금흐름:
$-38.94M
1주 성능:
-19.02%
1개월 성능:
+10.17%
6개월 성능:
-8.55%
1년 성능:
-90.88%
1일 변동 폭
Value
$5.86
$6.78
1주일 범위
Value
$5.86
$8.16
52주 변동 폭
Value
$3.816
$73.40

Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile

Name
명칭
Verrica Pharmaceuticals Inc
Name
전화
484-453-3300
Name
주소
10 NORTH HIGH STREET, WEST CHESTER, PA
Name
직원
71
Name
트위터
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
VRCA's Discussions on Twitter

VRCA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VRCA
Verrica Pharmaceuticals Inc
6.61 64.74M 5.12M -67.00M -38.94M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-06 다운그레이드 H.C. Wainwright Buy → Neutral
2024-11-05 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-07-25 업그레이드 Needham Hold → Buy
2023-03-22 개시 Jefferies Buy
2023-02-13 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2022-05-25 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2021-05-14 개시 RBC Capital Mkts Outperform
2020-12-24 재확인 H.C. Wainwright Buy
2020-07-15 다운그레이드 BofA Securities Buy → Neutral
2020-06-30 재확인 H.C. Wainwright Buy
2020-06-24 개시 Northland Capital Outperform
2020-03-24 개시 Needham Buy
2019-02-21 개시 H.C. Wainwright Buy
모두보기

Verrica Pharmaceuticals Inc 주식(VRCA)의 최신 뉴스

pulisher
05:57 AM

Verrica Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Consultation - Newser

05:57 AM
pulisher
05:13 AM

Why Verrica Pharmaceuticals Inc. stock attracts strong analyst attentionFree Smart Money Stock Analysis - Newser

05:13 AM
pulisher
05:09 AM

How does Verrica Pharmaceuticals Inc. compare to its industry peersBuild a balanced portfolio for long-term success - jammulinksnews.com

05:09 AM
pulisher
03:56 AM

Is Verrica Pharmaceuticals Inc. stock overhyped or has real potentialFree Stock Portfolio Optimization - Newser

03:56 AM
pulisher
Jul 25, 2025

What analysts say about Verrica Pharmaceuticals Inc. stockExceptional return forecasts - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Verrica Pharmaceuticals Inc. stock priceFree Stock Selection - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

VRCA Trading Halted: Anticipation Builds for Pending Announcemen - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Is Verrica Pharmaceuticals Inc. stock a good hedge against inflationRemarkably fast returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit velocity - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals to implement 1-for-10 reverse stock split By Investing.com - Investing.com South Africa

Jul 23, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals Announces Reverse Stock Split - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Verrica Pharmaceuticals to implement 1-for-10 reverse stock split - Investing.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Verrica Pharmaceuticals Inc. a good long term investmentAccelerated earnings growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 07:38:47 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What institutions are buying Verrica Pharmaceuticals Inc. stock nowDaily Trade Opportunity - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Verrica Pharmaceuticals Inc. stock price move sharplyInsider Strategy Insight - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Verrica Pharmaceuticals Inc. stock performs during market volatilityFree Stock Trading Community - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives $8.00 Average Target Price from Brokerages - Defense World

Jul 14, 2025
pulisher
Jul 10, 2025

Verrica Reports Strong Q2 Growth as YCANTH Demand Accelerates - MyChesCo

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Shares Down 4.9% – Should You Sell? - Defense World

Jul 10, 2025
pulisher
Jul 10, 2025

Verrica Pharmaceuticals reports 32.8% quarterly growth in YCANTH sales By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 | VRCA Stock News - GuruFocus

Jul 09, 2025

Verrica Pharmaceuticals Inc (VRCA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Verrica Pharmaceuticals Inc 주식 (VRCA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Hayes Christopher G.
CHIEF LEGAL OFFICER
Aug 26 '24
Sale
2.66
26,183
69,647
115,303
Hayes Christopher G.
CHIEF LEGAL OFFICER
Aug 27 '24
Sale
2.46
9,530
23,444
105,773
Goldenberg Gary
Chief Medical Officer
Aug 26 '24
Sale
2.66
9,888
26,302
97,862
Goldenberg Gary
Chief Medical Officer
Aug 27 '24
Sale
2.46
3,601
8,858
94,261
Bonaccorso Joe
CHIEF COMMERCIAL OFFICER
Aug 26 '24
Sale
2.66
24,709
65,726
82,107
Bonaccorso Joe
CHIEF COMMERCIAL OFFICER
Aug 27 '24
Sale
2.46
8,993
22,123
73,114
Kohler Terry
CHIEF FINANCIAL OFFICER
Aug 26 '24
Sale
2.66
21,820
58,041
52,596
Kohler Terry
CHIEF FINANCIAL OFFICER
Aug 27 '24
Sale
2.46
7,899
19,432
44,697
White Ted
PRESIDENT AND CEO
Aug 26 '24
Sale
2.66
24,979
66,444
224,988
White Ted
PRESIDENT AND CEO
Aug 27 '24
Sale
2.46
9,021
22,192
215,967
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):